SLNO
Soleno Therapeutics Inc

8,168
Mkt Cap
$2.64B
Volume
563,255.00
52W High
$90.32
52W Low
$41.50
PE Ratio
-25.87
SLNO Fundamentals
Price
$47.65
Prev Close
$49.14
Open
$49.06
50D MA
$53.67
Beta
0.81
Avg. Volume
2.58M
EPS (Annual)
-$4.38
P/B
5.17
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving Average - What's Next?
Soleno Therapeutics (NASDAQ:SLNO) Stock Crosses Below 50 Day Moving Average - Here's What Happened...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc...
PR Newswire·10d ago
News Placeholder
34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC
Castleark Management LLC bought a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·12d ago
News Placeholder
Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP
Holocene Advisors LP cut its holdings in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 3.7% in the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·13d ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Still a Buy?
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Still a Buy...
MarketBeat·15d ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - What's Next?
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Time to Buy...
MarketBeat·15d ago
News Placeholder
Diadema Partners LP Has $23.81 Million Stock Position in Soleno Therapeutics, Inc. $SLNO
Diadema Partners LP grew its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 197.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm...
MarketBeat·17d ago
News Placeholder
Soleno Therapeutics, Inc. $SLNO Stake Reduced by Vivo Capital LLC
Vivo Capital LLC reduced its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 11.2% in the second quarter, according to its most recent filing with the Securities...
MarketBeat·18d ago
News Placeholder
Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO
Marshall Wace LLP raised its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 133.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·18d ago
News Placeholder
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) has received an average rating of "Buy" from the fifteen brokerages that are currently covering the firm, Marketbeat.com reports. One...
MarketBeat·21d ago
<
1
2
...
>

Latest SLNO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.